Sichenzia Ross Ference Kesner LLP Congratulates AYTU Biosciences, Inc., on NASDAQ Uplisting
Press Release – New York, NY – October 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that the Firm represented AYTU Biosciences, Inc. (NASDAQ: AYTU), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Partner Marcelle Balcombe. The up-listing is effective for trading on October 20, 2017 and AYTU’s common stock will trade under its existing stock symbol “AYTU.”
“We congratulate AYTU on this milestone, one we believe will support the Company’s strategic capital markets objectives as it continues to market its therapies for low testosterone in men and diagnosing male infertility,” said Gregory Sichenzia, founding partner of Sichenzia Ross Ference Kesner LLP.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock - June 11, 2019
- New Jersey Bureau of Securities Proposes New Rule to Create State-Level Fiduciary Duties For Broker-Dealers, Associated Persons, Investment Advisers and Investment Adviser Representatives - June 11, 2019
- Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million - June 11, 2019